Recorded device evidence

SU-POR Patient-Specific Cranial Implant, SU-POR Patient-Specific Facial Implant (K152463): indications, design and recorded evidence

The acquired K152463 file contains product-specific indications and users, design and operating principle, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 1 selected decisions under primary code FWP. 1 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K152463 ↗ · this pageSU-POR Patient-Specific Cranial Implant, SU-POR Patient-Specific Facial Implant2015-08-28 → 2016-01-20145Traditional
K254233 ↗MEDPOR Customized Implant Kit2025-12-29 → 2026-03-1273Special
K232593 ↗FITme Customized Silicone Implant2023-08-25 → 2023-11-2289Traditional
K200610 ↗Customized Contour Implant2020-03-09 → 2020-12-23289Traditional
K191130 ↗Customized Contour Implant2019-04-29 → 2019-08-23116Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 3 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K152463 · PDF page 5 ↗ Source 2

SU-POR Patient-Specific Surgical Implants in customized shapes to meet the
needs of individual patients             are intended for non-                                                weight-bearing applications of
craniofacial reconstruction/cosmetic surgery and repair of craniofacial trauma.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K152463 · PDF page 4 ↗ Source 3

T he SU-POR Patient-Specific Surgical Implant is provided as a kit of  t wo  identical
implants, one of which serves as a back-up implant.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Performance evidence actually described

K152463 · PDF page 6 ↗ Source 4

There is no change in the material, duration, or location of contact or sterilization
method f rom  the cleared predicate SU-POR Surgical Implants - K140437.
Therefore, biocompatibility was not required as a basis for substantial
equivalence.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK152463 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categorySU-POR Patient-Specific Cranial Implant, SU-POR Patient-Specific Facial Implant [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantPoriferous, LLC [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeFWP [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2016-01-20 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2015-08-28 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

What needs to happen first

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[58142] · record ca3a1886568a0f59390785a712471b30f53f967c6f8126b925279f1c74b402ae
  • [5] Complete results array / fda-decision-context:K152463 · record whole dataset partition

FDA 510(k) summary — K152463 ↗

Wed, 03 Feb 2016 17:44:01 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 83e809b199b6c8dfecb363852a36adc57ed99356e13f9b349b0a70e1146566dd

  • [2] PDF page 5 · record e5de44d8e98c76c10724fcb2c5fa4f19cbb20c951f4f0d2cf82d9153fcb9a8e6
  • [3] PDF page 4 · record 4449b003903a9637b6083d62c4102dd45546613711f73791930ec31aa98c70c8
  • [4] PDF page 6 · record ab9eebe783a2f845a963c360674e89ef1a3424b51fd66fa07160d4db850729f8

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services

Biocompatibility Testing (ISO 10993 Program) · Sterilization + Microbiology Validation